Evid Science, a digital health company that broadens access to outcomes evidence, has named Marc L Berger, MD as its new scientific advisor, it was reported yesterday.

Dr Berger was former vice president of Real World Data and Analytics at Pfizer Inc and he retired in July 2017. Prior to Pfizer, he held the position of executive vice president and senior scientist in the life sciences group of OptumInsight, part of United Health Group. Before that, he served as the vice president, Global Health Outcomes at Eli Lilly and Company and vice president of Outcomes Research and Management at Merck & Co Inc. He currently chairs the Product Advisory Board at SHYFT Analytics. He has served on the Medicare Evidence Development & Coverage Advisory Committee for CMS and the steering committee for the AHRQ Centers for Research and Education on Therapeutics He also served on the board of the International Society for Pharmacoeconomics and Outcomes Research where he chaired or participated in a number of ISPOR Good Research Practice Taskforces.

Matt Michelson, CEO of Evid Science, said, 'We are thrilled to have Marc join our Scientific Advisory board, and look forward to his contributions. Marc is a pioneer in Health Economics and Outcomes Research. He brings both the expertise and vision to help us improve our business and our technology. His experience across a number of the world's largest healthcare organisations, and as an advisor to successful start-ups, will be invaluable as we continue to innovate on the collection and use of medical evidence.'